UNIGE document Scientific Article
previous document  unige:99342  next document
add to browser collection
Title

Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists

Authors
Nagler, M
Angelillo-Scherrer, A
Méan, M
Abbal, C
Beer, J H
Osterwalder, J
show hidden authors show all authors [1 - 20]
Published in Journal of Thrombosis and Haemostasis. 2017, vol. 15, p. 2165-2175
Abstract The long-term effect of polymorphisms of the vitamin K-epoxide reductase (VKORC1) and the cytochrome P450 enzyme gene (CYP2C9) on clinical outcomes remains unclear.
Identifiers
PMID: 28834238
Full text
Article (Published version) (466 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group La maladie thromboembolique veineuse (808)
Citation
(ISO format)
NAGLER, M et al. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. In: Journal of Thrombosis and Haemostasis, 2017, vol. 15, p. 2165-2175. https://archive-ouverte.unige.ch/unige:99342

18 hits

0 download

Update

Deposited on : 2017-11-22

Export document
Format :
Citation style :